Abstract: Studies assessing the effects of vitamin D or calcium intake on breast cancer risk have been inconclusive. Furthermore, few studies have evaluated them jointly. This study is the largest so far examining the association of dietary vitamin D and calcium intake with breast cancer risk in the European Prospective Investigation into Cancer and Nutrition. During a mean follow-up of 8.8 yr, 7760 incident invasive breast cancer cases were identified among 319,985 women. Multivariable Cox proportional hazards regression was used to estimate hazard ratios (HR) and 95% confidence intervals (CI) for pre-and postmenopausal breast cancer risk. Comparing the highest with the lowest quintile of vitamin D intake, HR and 95% CI were 1.07 (0.87-1.32) and 1.02 (0.90-1.16) for pre-and postmenopausal women, respectively. The corresponding HR and 95% CIs for calcium intake were 0.98 (0.80-1.19) and 0.90 (0.79-1.02), respectively. For calcium intake in postmenopausal women, the test for trend was borderline statistically significant (P(trend) = 0.05). There was no significant interaction between vitamin D and calcium intake and cancer risk (P(interaction) = 0.57 and 0.22 in pre-and postmenopausal women, respectively). In this large prospective cohort, we found no evidence for an association between dietary vitamin D or calcium intake and breast cancer risk. In this large prospective cohort, we found no evidence for an association between dietary vitamin D or calcium intake and breast cancer risk.
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Introduction
Both epidemiological and experimental data suggest an inverse association between vitamin D and breast cancer (1) (2) (3) . Besides its classical function on calcium homeostasis and bone metabolism, vitamin D has potential anticarcinogenic properties with regard to regulation of apoptosis, cell differentiation, cell growth and growth factor signaling (4) (5) (6) .
Studies assessing the association of vitamin D intake and breast cancer risk have yielded inconsistent results. A meta-analysis from 2010 that pooled 11 studies assessing vitamin D intake from either diet and/or supplements and breast cancer risk resulted in a significant overall association with a RR of 0.91 (0.85 -0.97) (7) . However, there was no significant association when assessing vitamin D intake from diet only. Another meta-analysis from 2008
reported no statistically significant association between dietary vitamin D intake from food or supplements and breast cancer risk (8) and from endogenous production after exposure to sunlight. Most case-control studies reported an inverse association between vitamin D status and breast cancer risk (9) . However, there was no statistically significant inverse association in cohort studies (9) , except for a recent study in the French E3N Cohort (10) . In addition, the Second Expert Report by the World Cancer Research Fund (WCRF) classified the evidence as limited (no conclusion) for both pre-and postmenopausal breast cancer (11) .
There is less scientific evidence with regard to the anticarcinogenic potential of calcium, though effects of calcium on cell proliferation and apoptosis have been reported (12, 13) .
However, due to the tight homeostasis of plasma calcium, it is unclear whether dietary calcium may affect breast cancer risk. Various studies assessed the association between dietary calcium intake and breast cancer risk with the majority reporting inverse associations (3) . A meta-analysis pooling data from 6 cohort and 9 case-control studies resulted in a statistically significant inverse association between calcium intake and breast cancer risk.
However, the results suggest an inverse association in pre-but not in postmenopausal women (7) .
Vitamin D intake varies considerably across countries, which may also lead to different risk estimates (8) 
Material and methods
Study population
EPIC is a large prospective cohort study conducted since 1992 in 23 
Exposure assessment
Diet over the previous twelve months was assessed using dietary assessment instruments that were specifically developed for each participating country (14) . The questions were structured by common food groups except for the questionnaires used in Italy and Spain, where questions were structured by country-specific meals.
All participants were asked to report their average consumption of each food item over the previous twelve months by structured categories ranging from never or less than once per month to six or more times per day. All dietary measurement instruments have been validated previously in a series of studies within the various source populations participating in EPIC (15) .
To collect information on education, medical history (surgeries and previous illnesses), tobacco and alcohol consumption, and physical activity and other lifestyle factors, a further questionnaire was used. Height and weight were measured at baseline, except for most participants recruited at the Oxford study center, and in France as well as all participants recruited in Norway. Self-reported data were available for the latter centres (14) .
Menopausal status at baseline was defined as described previously using an algorithm that accounts for information on menstrual status/history, type of menopause, use of oral contraceptives and menopausal hormones (16) .
Outcome assessment Abbas 8 In most countries (Denmark, Italy, The Netherlands, Norway, Spain, Sweden, and the UK) incident cancers were identified through linkage with population registries. Cancer cases were further identified by active follow-up, through a health insurance company (France) or direct contacts with study subjects, their doctors or their next of kin (France, Germany, and Greece). Mortality data were also obtained from either the cancer or mortality registries at the regional or national level. Participants from centers that relied on registry data that have been reported to IARC were censored between December 2002 and December 2005, depending on the study center. For Germany and Greece, the end of the follow up was considered to be the last known contact, the date of diagnosis, or the date of death, whichever came first. Cancer incidence was coded according to ICD-O-2.
Statistical analysis
Participants were categorized according to quintiles of dietary intake of vitamin D and calcium. Cox proportional hazards regression was used to examine the association of dietary intake of vitamin D or calcium and breast cancer risk. Age was used as the primary time variable in the Cox models. Time at entry was age at recruitment, exit time was age when participants were diagnosed with cancer, died, were lost to follow-up, or were censored at the end of the follow-up period, whichever came first. Analyses were stratified by center to account for center effects such as follow-up procedures and questionnaire design, and by 1-year categories of age at recruitment to account for possible violations of the proportional hazard assumption. 
Results
Mean follow-up time for the study population was 8. Table 1 . Women in the highest quintile of both vitamin D and calcium intake had a higher non-fat energy intake and a higher fat intake as compared to women in the lowest quintile. Furthermore, women in the lower quintile of vitamin D intake weighed less, used oral contraceptives less frequently, were younger at menarche, and were more often nonsmokers.
As shown in Table 2 , dietary vitamin D intake was highest in EPIC Sweden as compared to the other countries; calcium intake was highest in Denmark and the Netherlands.
Dietary vitamin D intake was not associated with overall breast cancer risk (p trend = 0.92; Table 3 ), There was also no association when addressing pre-or postmenopausal women separately.
We found some indication for an inverse association between dietary calcium intake and breast cancer risk. The hazard ratio (HR) (95% confidence interval (CI)) for the highest as compared to the lowest quintile was 0.91 (0.83-1.01) ( Table 3 ). The test for trend did not In the complete case analysis results were similar to those when using confounders with a category for missing data for both dietary vitamin D and calcium intake.
As dietary vitamin D may modify the association between calcium intake and breast cancer risk (and vice versa), we assessed potential interaction effects between both nutrients.
However, statistical significant interaction (p-interaction = 0.44; 0.57 and 0.22 for all, premenopausal and postmenopausal women, respectively; data not shown) was not observed. In a country-specific analysis with the continuous calibrated intake values there was no statistically significant association between either vitamin D or calcium intake and overall breast cancer risk. Country-specific results by menopausal status also showed no significant associations except for an increased breast cancer risk associated with calcium intake in premenopausal women in the Netherlands (p = 0.01) (data not shown).
As a proxy for sun exposure and thus endogenous vitamin D production we divided the centres in 7 categories according to their latitude. Adjustment for latitude did not change the observed risk estimates for vitamin D and breast cancer risk. Moreover, we calculated Abbas 12 separate risk estimates for each latitude. There was no significant association between vitamin D and breast cancer risk in any of the latitude groups (p heterogeneity = 0.37).
Discussion
The present study is so far the largest prospective study including data from nine European reported no significant association between dietary vitamin D intake from food or supplements and breast cancer risk (8) . However, the authors observed a significant inverse association when restricting the analysis to women taking more than 10µg/day vitamin D.
Thus, the amount of dietary intake in the present population may be too low to detect a potential effect. Intake of dietary vitamin D in the present study was somehow comparable with dietary intake, but not total intake values reported in US studies (20, 21) . In contrast, Abbas 13 dietary calcium intake in EPIC is somehow higher than reported dietary intake in the US (20, 21) . Unfortunately, we did not have information on supplemental vitamin D intake nor on sun exposure as primary source of vitamin D. We, however, adjusted in the regression analysis for physical activity which may in part account for sun exposure, with a marginal effect on risk estimates. In a sensitivity analysis, we also adjusted for centers' latitude as another proxy for sun exposure, which also did not affect the risk estimates. yielded mostly significant inverse associations in case-control studies but, except for one study (10) , no associations with risk in cohort studies (9).
We did not observe a statistically significant association between dietary calcium and breast cancer risk in pre-or postmenopausal women. However, we found some indication of an inverse association in postmenopausal women with borderline significance (p trend = 0.05).
Most case-control studies reported an inverse association (37) (38) (39) (40) (41) (42) (43) (44) (45) (46) , although statistically significant only in a subset (40, 41, 45, 46) and no association was observed in three studies in premenopausal women only (30, 31, 34) . Cohort studies reported a reduced risk of breast cancer associated with dietary calcium (20, 21, 24, 47, 48) , including two studies in premenopausal women only (20, 24) and one in estrogen receptor-/progesterone receptornegative tumors only (48), or no significant association (33, 49) . The results of the largest trial so far, the Women's Health Initiative, did not demonstrate an inverse association between breast cancer risk and calcium plus vitamin D supplementation (50) . However, a recent reanalysis of the WHI data provided evidence for a protective effect of vitamin D and calcium supplementation in women who were not taking further personal supplements, indicating that supplementation may only be effective in those women who were deficient (51).
Calcium might exert its potential anticarcinogenic properties via several mechanisms including effects on cell proliferation, apoptosis or cell differentiation (3, 12, 13) . So far, differential anticarcinogenic mechanisms on pre-and postmenopausal breast cancer are not known. However, a meta-analysis pooling data from 15 studies reported a statistically significant inverse association in pre-/perimenopausal women but not postmenopausal women (7) .
Further studies have concentrated on measurement of calcium in serum samples as a marker of a subject's calcium status (52) (53) (54) . Results have been inconsistent, showing significant positive (53) or negative associations (52) in premenopausal women or no significant association at all (54) . However, as the calcium metabolism and thus serum calcium levels are tightly regulated, blood levels of calcium may not be a good marker for calcium status or dietary calcium intake (55).
In line with previous studies, our results do not suggest an interaction between vitamin D and calcium intake (20, 33, 34) , nor that the associations were confounded by each other. In contrast, another study reported a borderline significant interaction between both nutrients in postmenopausal women (p = 0.05) with a non-significant inverse association for calcium intake in the group with the highest tertile vitamin D intake (24) .
Strengths of the study are its prospective design, the calibration of food frequency questionnaire data against 24-h-recall data to reduce measurement error, as well as the inclusion of participants from different European countries reflecting a wide range of intake. The manuscript has not been published and has not been submitted simultaneously for publication elsewhere. 
